Relay Therapeutics Inc (RLAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 25,202 | 119 | 226 | 253 | 344 |
| Gross Profit | 25,202 | 119 | 226 | 253 | 344 |
| Operating Expenses | 98,779 | 106,169 | 101,403 | 73,104 | 86,236 |
| Operating Income | -73,577 | -106,050 | -101,177 | -72,851 | -85,892 |
| Other Income | 7,843 | 7,545 | 6,938 | 5,348 | 1,720 |
| Pre-tax Income | -65,734 | -98,505 | -94,239 | -67,503 | -84,172 |
| Net Income Continuous | -65,734 | -98,505 | -94,239 | -67,503 | -84,172 |
| Net Income | $-65,734 | $-98,505 | $-94,239 | $-67,503 | $-84,172 |
| EPS Basic Total Ops | -0.54 | -0.81 | -0.78 | -0.55 | -0.76 |
| EPS Basic Continuous Ops | -0.54 | -0.81 | -0.78 | -0.55 | -0.76 |
| EPS Diluted Total Ops | -0.54 | -0.81 | -0.78 | -0.55 | -0.76 |
| EPS Diluted Continuous Ops | -0.54 | -0.81 | -0.78 | -0.55 | -0.76 |
| EBITDA(a) | $-75,090 | $-106,917 | $-101,997 | $-72,070 | $-84,519 |